A pooled analysis of the efficacy and safety of sunitinib in elderly patients (pts) with metastatic renal cell carcinoma (mRCC).
T. E. Hutson
Consultant or Advisory Role - AVEO; GlaxoSmithKline; Novartis; Pfizer; Wyeth
Honoraria - AVEO; GlaxoSmithKline; Novartis; Pfizer
Research Funding - AVEO; GlaxoSmithKline; Novartis; Pfizer; Wyeth
R. M. Bukowski
Consultant or Advisory Role - Argos Therapeutics; Genentech; GlaxoSmithKline; Novartis; Vicus Therapeutics
Honoraria - Novartis; Pfizer; Roche/Genentech
B. I. Rini
Consultant or Advisory Role - AVEO; GlaxoSmithKline; Pfizer
Research Funding - GlaxoSmithKline; Pfizer
M. E. Gore
Consultant or Advisory Role - AVEO; GlaxoSmithKline; Novartis; Pfizer; Wyeth
Honoraria - AVEO; GlaxoSmithKline; Novartis; Pfizer
J. M. G. Larkin
Consultant or Advisory Role - Pfizer
Honoraria - Pfizer
Research Funding - Pfizer
R. A. Figlin
Consultant or Advisory Role - Pfizer
Research Funding - Pfizer
C. H. Barrios
Consultant or Advisory Role - Pfizer
B. Escudier
Consultant or Advisory Role - AVEO; Bayer; GlaxoSmithKline; Novartis; Pfizer; Roche
Honoraria - AVEO; Bayer; GlaxoSmithKline; Novartis; Pfizer; Roche
X. Lin
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
K. D. Fly
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer (B)
B. Martell
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
Other Remuneration - Pfizer
E. Matczak
No relevant relationships to disclose
R. J. Motzer
Research Funding - Pfizer